Company record
Mallinckrodt Hospital Products Inc.
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Mallinckrodt Hospital Products Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Sep 2 | Class II | Mallinckrodt Hospital Products Inc. Drug |
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2 Presence of particulate matter: glass and stopper piece |